These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 39314522)

  • 21. The causal association between polycystic ovary syndrome and susceptibility and severity of COVID-19: a bidirectional Mendelian randomization study using genetic data.
    Si Y; Fei Y; Ma H; Xu Y; Ning L; Li X; Ren Q
    Front Endocrinol (Lausanne); 2023; 14():1229900. PubMed ID: 37745707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A metabolome-wide Mendelian randomization study prioritizes causal circulating metabolites for reproductive disorders including primary ovarian insufficiency, polycystic ovary syndrome, and abnormal spermatozoa.
    Chen S; Sun S; Cai M; Zhou Z; Ma Y; Zhou Z; Wang F; Liu J; Song W; Liu Y; Huang K; Yang Q; Guo Y
    J Ovarian Res; 2024 Aug; 17(1):166. PubMed ID: 39143642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. No association effect of genetic polymorphism was observed between polycystic ovary syndrome and cardiovascular diseases risk: a mendelian randomization study.
    Zhang X; Huangfu Z; Wang S
    Endocrine; 2023 Dec; 82(3):695-706. PubMed ID: 37668928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Causal relationships between modifiable risk factors and polycystic ovary syndrome: a comprehensive Mendelian randomization study.
    Zhao Y; Pang J; Fang X; Yan Z; Yang H; Deng Q; Ma T; Lv M; Li Y; Tu Z; Zou L
    Front Endocrinol (Lausanne); 2024; 15():1348368. PubMed ID: 38779450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic evidence for the causal association between type 1 diabetes and the risk of polycystic ovary syndrome.
    Chen S; Guo Z; Yu Q
    Hum Genomics; 2023 Nov; 17(1):100. PubMed ID: 37957681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of novel protein biomarkers and drug targets for colorectal cancer by integrating human plasma proteome with genome.
    Sun J; Zhao J; Jiang F; Wang L; Xiao Q; Han F; Chen J; Yuan S; Wei J; Larsson SC; Zhang H; Dunlop MG; Farrington SM; Ding K; Theodoratou E; Li X
    Genome Med; 2023 Sep; 15(1):75. PubMed ID: 37726845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic correlation, shared loci, and causal relationship between obesity and polycystic ovary syndrome: a large-scale genome-wide cross-trait analysis.
    Liu Q; Zhu Z; Kraft P; Deng Q; Stener-Victorin E; Jiang X
    BMC Med; 2022 Feb; 20(1):66. PubMed ID: 35144605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A genetic risk score is associated with polycystic ovary syndrome-related traits.
    Lee H; Oh JY; Sung YA; Chung HW
    Hum Reprod; 2016 Jan; 31(1):209-15. PubMed ID: 26573528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-causal relationship of polycystic ovarian syndrome with homocysteine and B vitamins: evidence from a two-sample Mendelian randomization.
    Su N; Li J; Xia Y; Huang C; Chen L
    Front Endocrinol (Lausanne); 2024; 15():1393847. PubMed ID: 38841299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Genetic Association of Polycystic Ovary Syndrome and the Risk of Endometrial Cancer: A Mendelian Randomization Study.
    Chen H; Zhang Y; Li S; Tao Y; Gao R; Xu W; Yang Y; Cheng K; Wang Y; Qin L
    Front Endocrinol (Lausanne); 2021; 12():756137. PubMed ID: 34803918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Causality of anthropometric markers associated with polycystic ovarian syndrome: Findings of a Mendelian randomization study.
    De Silva K; Demmer RT; Jönsson D; Mousa A; Teede H; Forbes A; Enticott J
    PLoS One; 2022; 17(6):e0269191. PubMed ID: 35679284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between genetically predicted polycystic ovary syndrome and ovarian cancer: a Mendelian randomization study.
    Harris HR; Cushing-Haugen KL; Webb PM; Nagle CM; Jordan SJ; ; Risch HA; Rossing MA; Doherty JA; Goodman MT; Modugno F; Ness RB; Moysich KB; Kjær SK; Høgdall E; Jensen A; Schildkraut JM; Berchuck A; Cramer DW; Bandera EV; Rodriguez L; Wentzensen N; Kotsopoulos J; Narod SA; McLaughlin JR; Anton-Culver H; Ziogas A; Pearce CL; Wu AH; Lindström S; Terry KL
    Int J Epidemiol; 2019 Jun; 48(3):822-830. PubMed ID: 31211375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of genetic variants for blood insulin level in sex-stratified Korean population and evaluation of the causal relationship between blood insulin level and polycystic ovary syndrome.
    Lim WY; Lee H; Cho YS
    Genes Genomics; 2021 Oct; 43(10):1105-1117. PubMed ID: 34304350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leveraging Northern European population history: novel low-frequency variants for polycystic ovary syndrome.
    Tyrmi JS; Arffman RK; Pujol-Gualdo N; Kurra V; Morin-Papunen L; Sliz E; ; Piltonen TT; Laisk T; Kettunen J; Laivuori H
    Hum Reprod; 2022 Jan; 37(2):352-365. PubMed ID: 34791234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Basic research in PCOS: are we reaching new frontiers?
    Ben-Shlomo I; Younis JS
    Reprod Biomed Online; 2014 Jun; 28(6):669-83. PubMed ID: 24768413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thyroid function and polycystic ovary syndrome: a Mendelian randomization study.
    Zhao Z; Gao Y; Pei X; Wang W; Wang R; Zhang H
    Front Endocrinol (Lausanne); 2024; 15():1364157. PubMed ID: 38586452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age at menarche and polycystic ovary syndrome: A Mendelian randomization study.
    Ma Y; Cai J; Liu LW; Hou W; Wei Z; Wang Y; Xu Y
    Int J Gynaecol Obstet; 2023 Sep; 162(3):1050-1056. PubMed ID: 37128830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fetal genome predicted birth weight and polycystic ovary syndrome in later life: a Mendelian randomization study.
    Liu D; Gan Y; Zhang Y; Cui L; Tao T; Zhang J; Zhao J
    Front Endocrinol (Lausanne); 2023; 14():1140499. PubMed ID: 37351103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetically predicted high sex hormone binding globulin was associated with decreased risk of polycystic ovary syndrome.
    Guo X; Chen L; He J; Zhang X; Xu S
    BMC Womens Health; 2024 Jun; 24(1):357. PubMed ID: 38902677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Causal association of immune cells and polycystic ovarian syndrome: a Mendelian randomization study.
    Aru N; Yang C; Chen Y; Liu J
    Front Endocrinol (Lausanne); 2023; 14():1326344. PubMed ID: 38189053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.